Valuation : BrainsWay Ltd.

Market Cap 572M 174B 494M 465M 424M 795M 54.34B 801M 5.5B 2.14B 27.63B 2.15B 2.1B 91.68B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 572M 174B 494M 465M 424M 795M 54.34B 801M 5.5B 2.14B 27.63B 2.15B 2.1B 91.68B EV / Sales 2026 *
8.28x
EV / Sales 2027 * 6.71x
Free-Float
90.5%
Yield 2026 *
-
Yield 2027 * -
1 day-3.73%
1 week+0.79%
Current month-3.73%
1 month-11.88%
3 months-7.18%
6 months+17.41%
Current year+38.11%
1 week 4,153
Extreme 4153
4,483
1 month 4,153
Extreme 4153
5,075
Current year 3,080
Extreme 3080
5,165
1 year 2,391
Extreme 2391
5,165
3 years 631.1
Extreme 631.1
5,165
5 years 272
Extreme 272
5,165
10 years 272
Extreme 272
5,165
Manager TitleAgeSince
Chief Executive Officer 54 12/02/2023
Chief Tech/Sci/R&D Officer 56 30/04/2006
Director of Finance/CFO 50 22/05/2023
Director TitleAgeSince
Chairman 74 31/12/2002
Director/Board Member 70 31/10/2006
Director/Board Member 56 16/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/06/26 Sell

Founder

-3,000 0.0075%
26/05/26 Sell

Director

-7,980 0.0399%
20/05/26 Exercice

Director

41,080 0.1026%
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%+0.79%+64.36%+590.01% 600M
-2.69%-4.49%+21.87%+7.79% 228B
-3.10%-3.80%+0.54%-21.91% 150B
-2.02%-1.16%-21.98%+18.09% 133B
-0.46%-1.90%-54.43%-10.86% 70B
-0.01%+0.27%+11.56%+18.66% 52.31B
+0.43%-2.70%-16.93%-15.03% 50.59B
-2.36%-2.28%+19.31%+23.84% 43.3B
-2.12%-1.20%+34.47%+44.53% 40.74B
-3.64%-0.47%-15.72%+44.97% 34.63B
Average -1.73%-0.21%+4.31%+70.01% 80.36B
Weighted average by Cap. -1.69%-1.01%-0.23%+6.36%

Financials

2026 *2027 *
Net sales 69.16M 20.99B 59.66M 56.14M 51.18M 96.1M 6.57B 96.78M 665M 258M 3.34B 260M 254M 11.08B 85.33M 25.9B 73.62M 69.27M 63.14M 119M 8.1B 119M 821M 319M 4.12B 320M 313M 13.67B
Net income 12.38M 3.76B 10.68M 10.05M 9.16M 17.21M 1.18B 17.33M 119M 46.25M 598M 46.49M 45.48M 1.98B 20.96M 6.36B 18.09M 17.02M 15.51M 29.13M 1.99B 29.34M 202M 78.3M 1.01B 78.71M 76.99M 3.36B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
01/09/26 ILA 4,316.00 -3.73% 84,090
31/08/26 ILA 4,483.00 +3.99% 140,329
28/08/26 ILA 4,311.00 +0.07% 47,946
27/08/26 ILA 4,308.00 +1.10% 72,526
26/08/26 ILA 4,261.00 -1.84% 57,859

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BWAY Stock